26th Jan 2015 15:30
26 January 2015
BATM Advanced Communications Limited
("BATM" or the "Group")
Director Declaration
Further to BATM's announcement on 21 January 2015 that at the Extraordinary General Meeting of the Group to be held on 12 February 2015 shareholders will consider and, if thought fit, pass a resolution to appoint Dr. Avigdor Shafferman as an additional external director on the Board of the Group, the following information in respect of Dr. Shafferman is provided pursuant to Listing Rule 9.6.13.
Dr. Shafferman, aged 68, does not currently hold any directorships. From 1995 to 2013, he acted as Chairman of the Board of Directors of Life Science Research Israel Ltd, a governmental company dedicated to the commercialisations of innovative technologies and biotechnological products developed by the Israel Institute of Biological Research. There is no further information required to be disclosed in relation to Dr. Shafferman pursuant to Listing Rule 9.6.13 and Dr. Shafferman does not have any beneficial interest in BATM's ordinary shares.
Enquiries
BATM Advanced Communications | |
Dr. Zvi Marom, Chief Executive Officer | +972 9866 2525 |
Moti Nagar, Chief Financial Officer | |
finnCap | |
Stuart Andrews | +44 20 7220 0500 |
Shore Capital | |
Pascal Keane | +44 20 7408 4090 |
Luther Pendragon | |
Harry Chathli, Claire Norbury, Amelia Bullock-Muir | +44 20 7618 9100 |
Related Shares:
Batm Advanced